Skip to main content
. 2018 Oct 12;34(10):900–906. doi: 10.1089/aid.2017.0249

FIG. 3.

FIG. 3.

HIV-1 infection efficiency in LI and SI explants. Triplicate explants from (A) LI and (B) SI biopsies from all participants were infected with indicated doses of HIV-1BaL. Explants were considered “infected” if supernatant collected from designated day contained detectable p24 above a 100 ng/mL threshold. Data shown as the mean of the percentages of triplicate explants that met criteria for “infected” from all participants and error bars represent standard error.